Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Healthcare Industry News Cleo Diagnostics (ASX:COV) gains PLCO biobank access to strengthen FDA submission for ovarian cancer test Cleo Diagnostics secures PLCO biobank access to enhance its ovarian cancer test FDA filing. Find out how this milestone strengthens global regulatory strategy. byPallavi MadhirajuJune 25, 2025